Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | IGF1R | P08069 | 2/20 | 0.41 |
| ▸ | NAMPT | P43490 | 2/20 | 0.38 |
| ▸ | KIF11 | P52732 | 1/20 | 0.37 |
| ▸ | CYP2C9 | P11712 | 2/20 | 0.36 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.36 |
| ▸ | RXFP1 | Q9HBX9 | 2/20 | 0.35 |
| ▸ | AR | P10275 | 2/20 | 0.34 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.34 |
| ▸ | THRB | P10828 | 1/20 | 0.34 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6171908 | 0.89 | NAMPT (0.49) | IGF1RNAMPTCYP2C9 | |
| SCHEMBL6174113 | 0.88 | IGF1R (0.40) | IGF1RNAMPTCYP2C9CYP3A4GAA | |
| SCHEMBL6174680 | 0.88 | IGF1R (0.37) | IGF1RNAMPTCYP2C9CYP3A4GAA | |
| SCHEMBL6175557 | 0.86 | GAA (0.36) | IGF1RNAMPTCYP2C9CYP3A4GAA | |
| SCHEMBL6176020 | 0.86 | IGF1R (0.40) | IGF1RNAMPTCYP2C9CYP3A4GAA | |
| SCHEMBL6174087 | 0.85 | IGF1R (0.40) | IGF1RNAMPTCYP2C9CYP3A4GAA | |
| SCHEMBL6176657 | 0.85 | CYP3A4 (0.40) | NAMPTCYP2C9CYP3A4GAACYP2C19 | |
| SCHEMBL6174555 | 0.85 | IGF1R (0.40) | IGF1RNAMPTCYP2C9CYP3A4GAA | |
| SCHEMBL6176685 | 0.84 | IGF1R (0.39) | IGF1RNAMPTCYP2C9CYP3A4GAA | |
| SCHEMBL6172432 | 0.84 | ALDH1A1 (0.38) | IGF1RNAMPTCYP2C9CYP3A4GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1599464-A2 | NOVEL CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | Aventis Pharma S.A. (FR) | 2005-11-30 | — | — | EP | disclosed |
| WO-2004070050-A2 | CYCLIC UREA DERIVATIVES, PREPARATION METHOD THEREOF AND PHARMACEUTICAL USE OF SAME AS KINASE INHIBITORS | AVENTIS PHARMA S.A. (FR) | 2004-08-19 | — | — | WO | disclosed |